SLC12A3 rs4960191: What Your Genotype Means
The rs4960191 variant is a genetic polymorphism located within the SLC12A3 gene, which encodes a critical protein for kidney function. Research suggests this variant may be associated with variations in how the body handles electrolytes, blood pressure regulation, and individual responses to thiazide diuretic medications.
What each genotype means
Typical SLC12A3 profile
This genotype represents the most common form of the SLC12A3 gene variant. Research into this specific polymorphism is limited, and current evidence does not suggest a significant impact on renal electrolyte handling or blood pressure regulation for individuals with this profile.
This is the most frequent genotype observed globally, carried by the majority of the population.
Common variant carrier
Carrying one copy of the minor allele is a common observation in global populations. While the SLC12A3 gene is involved in kidney salt reabsorption and thiazide diuretic sensitivity, the clinical significance of this specific variant remains unclear and is not considered a primary driver of blood pressure variation.
This genotype is observed in a significant portion of the population, consistent with minor allele frequencies ranging from 0.10 to 0.22.
Minor allele homozygous
This genotype represents the homozygous state for the minor allele of this variant. While SLC12A3 variants are studied for their potential role in thiazide diuretic response and electrolyte balance, the evidence linking this specific polymorphism to clinical outcomes is limited and inconsistent. Please discuss any concerns regarding medication response or blood pressure management with your clinician or pharmacist.
This genotype is less common than the others, occurring at frequencies consistent with the reported minor allele frequency of 0.10 to 0.22.
Understanding the rs4960191 Variant
The rs4960191 variant is a single nucleotide polymorphism (SNP) found within the SLC12A3 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The SLC12A3 gene is located on chromosome 16 and provides instructions for creating the thiazide-sensitive sodium-chloride cotransporter (NCC). This protein is primarily expressed in the distal convoluted tubule of the kidney, where it plays a vital role in maintaining the body's electrolyte balance by reabsorbing sodium and chloride from the urine back into the bloodstream. Because this transporter is the primary target for a common class of blood pressure medications known as thiazide diuretics, variations in the gene that encodes it are of significant interest to researchers studying cardiovascular health and pharmacology.
The Role of SLC12A3 in Kidney Function
The SLC12A3 gene is essential for the regulation of blood pressure and fluid volume. By facilitating the reabsorption of sodium and chloride, the NCC protein helps determine how much salt is excreted in the urine. When this system functions normally, it helps keep blood pressure within a healthy range. However, when the SLC12A3 gene is affected by certain rare, inactivating mutations, it can lead to Gitelman syndrome, a condition characterized by salt wasting, low potassium, and low magnesium levels. While rs4960191 is a common polymorphism rather than a rare disease-causing mutation, it sits within the same gene, leading scientists to investigate whether it might contribute to more subtle differences in how individuals process salt and respond to blood pressure-lowering therapies.
Research Associations and Evidence Strength
Current research into rs4960191 has explored its potential links to blood pressure variation and sensitivity to thiazide diuretics. While some studies have identified statistical associations between SLC12A3 variants and blood pressure, the evidence for rs4960191 specifically remains limited. It is important to note that genetic associations are often complex and influenced by many factors, including diet, lifestyle, and other genetic markers. Because the evidence is not definitive, this variant is not currently used in clinical settings to predict individual health outcomes or to guide specific medical treatments. Researchers continue to study these associations to better understand the genetic architecture of hypertension, but findings should be viewed as preliminary rather than diagnostic.
Population Frequency
The rs4960191 variant is observed globally across diverse ancestral populations. Data from large-scale genomic databases indicate that the minor allele frequencies for this SNP typically range between 0.10 and 0.22, making it a relatively common genetic variation in the human population.
What This Information Means for You
If you have received information about your rs4960191 genotype, it is important to understand that this is a common genetic variation and not a diagnosis of any medical condition. Genetic markers like this one provide insight into biological diversity but do not determine your health destiny. You cannot use this information to self-diagnose or to make changes to your medication regimen. If you are currently taking thiazide diuretics or other blood pressure medications, do not alter your dosage or stop taking your medication based on genetic test results. Always discuss your genetic information with your clinician or a qualified pharmacist, as they can interpret these findings in the context of your overall health history, current medications, and clinical needs.
How common is this variant?
The rs4960191 variant is observed globally with minor allele frequencies typically ranging between 0.10 and 0.22 across various ancestral groups.
Frequently asked questions
Does the rs4960191 variant cause Gitelman syndrome?
No, rs4960191 is a common polymorphism and is not considered a cause of Gitelman syndrome. Gitelman syndrome is typically caused by rare, inactivating mutations in the SLC12A3 gene that significantly disrupt the function of the sodium-chloride cotransporter.
Can I use my rs4960191 genotype to choose my blood pressure medication?
No, you should not use this genetic information to choose or change your medication. Decisions regarding blood pressure treatment should be made exclusively by your healthcare provider based on your clinical symptoms, blood pressure readings, and medical history.
Is rs4960191 a reliable predictor of hypertension?
Current evidence does not support using rs4960191 as a reliable predictor of hypertension. While some studies have explored links between SLC12A3 variants and blood pressure, the association for this specific SNP is limited and not strong enough for clinical use.
Where can I find more information about my genetic results?
You can discuss your results with a primary care physician, a cardiologist, or a genetic counselor. These professionals can help you understand the limitations of genetic testing and how it relates to your personal health.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4960191?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29